About this trial
The study aims to assess the efficacy and safety of electroacupuncture among men with benign prostatic hyperplasia (BPH), compared with sham electroacupuncture.
Eligibility criteria
Qualifiers
Diagnosis of BPH in accordance with the European Association of Urology (EAU) guideline;
Male participants aged between 40 and 80 years;
Lower urinary tract symptoms (LUTS) for at least three months;
IPSS total score ≥8;
Disqualifiers
Post-void residual urine volume (PVR) ≥150 mL;
Acute urinary retention or catheterization for outflow obstruction within the 3 months (Except for post-surgical disposable catheterization);
Prostate cancer or prostate-specific antigen (PSA) level ≥4.0 ng/mL;
Neurogenic lower urinary tract dysfunction; prostatitis; uncontrolled symptomatic urinary tract infections; urethral strictures; bladder diverticula; bladder stones; bladder cancer; history of genitourinary system surgery (prostate, bladder, urethra, etc.);
Trial design
Treatments tested in this trial
- Electroacupuncture
- Sham electroacupuncture